Sana Biotechnology Inc.
SANA | NASDAQ
$3.15
+$0.05 (+1.61%)
Sep 22, 2026, 10:37 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 12.75M | n/a | n/a | n/a | n/a | 10.17M |
Gross Profit | -12.75M | n/a | n/a | n/a | n/a | -10.17M |
Operating Income | -190.96M | -272.72M | -293.14M | -272.56M | -356.91M | -161.12M |
Interest Income | 3.85M | 10.47M | 9.94M | 3.76M | 676K | 747K |
Pretax Income | -244.17M | -266.76M | -283.26M | -269.48M | -355.93M | -297.21M |
Net Income | -244.17M | -266.76M | -283.26M | -269.48M | -355.93M | -285.31M |
Selling & General & Admin | 44.3M | 64.04M | 73.3M | 71.56M | 50.41M | 28.27M |
Research & Development | 131.98M | 208.68M | 219.84M | 201M | 306.5M | 122.68M |
Other Expenses | 1.93M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 178.21M | 272.72M | 293.14M | 272.56M | 356.91M | 150.95M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 190.96M | 272.72M | 293.14M | 272.56M | 356.91M | 161.12M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -11.9M |
Shares Outstanding (Basic) | 253.23M | 230.89M | 194.54M | 188.34M | 166.43M | 187.51M |
Shares Outstanding (Diluted) | 253.23M | 230.89M | 194.54M | 188.34M | 166.43M | 187.51M |
EPS (Basic) | -0.96 | -1.16 | -1.46 | -1.43 | -2.14 | -1.63 |
EPS (Diluted) | -0.96 | -1.16 | -1.46 | -1.43 | -2.14 | -1.63 |
EBITDA | -231.42M | -249.37M | -258.7M | -253.85M | -344.86M | -287.03M |
EBIT | -244.17M | -266.76M | -283.26M | -269.48M | -355.93M | -297.21M |
Depreciation & Amortization | 12.75M | 17.39M | 24.56M | 15.63M | 11.07M | 10.17M |
Add to Watchlist
Select watchlists to add or remove SANA